History

Documents created during the development process.

Background information

TA124 Lung cancer (non-small-cell) - pemetrexed: review decision - May 2012 information
Appendix A: decision paper presented to the Institute's Guidance Executive
Appendix A: decision paper presented to the Institute's Guidance Executive (PDF 148 KB)

Published:

30 May 2012
Lung cancer (non-small-cell) - pemetrexed: review proposal - July 2011 information
Appendix A: provisional matrix of stakeholders
Appendix A: provisional matrix of stakeholders (PDF 65 KB)

Published:

04 July 2011
Appendix B: proposal paper presented to the Institute's Guidance Executive
Appendix B: proposal paper presented to the Institute's Guidance Executive (PDF 168 KB)

Published:

04 July 2011
Review Decision - March 2010 information
Appendix A: Decision paper considered by the Institute's Guidance Executive
Appendix A: Decision paper considered by the Institute's Guidance Executive (PDF 88 KB)

Published:

17 March 2010
Review Proposal - August 2009 information
A full list of the organisations contacted for this review
A full list of the organisations contacted for this review (PDF 32 KB)

Published:

26 August 2009
Proposal paper considered by the Institute's Guidance Executive
Proposal paper considered by the Institute's Guidance Executive (PDF 150 KB)

Published:

26 August 2009
TA124 Lung cancer (non-small cell) - pemetrexed: distribution list
TA124 Lung cancer (non-small cell) - pemetrexed: distribution list (PDF 18 KB)

Published:

22 August 2007
NICE issues guidance on pemetrexed (Alimta) for the treatment of non-small-cell lung cancer information
NICE issues guidance on pemetrexed (Alimta) for the treatment of non-small-cell lung cancer (PDF 34 KB)

Published:

22 August 2007

Lung cancer (non-small cell) - pemetrexed: appeal documents

Eli Lilly and Company Limited
Appeals received
Appeals received (PDF 56 KB)

Published:

06 June 2007
Initial scrutiny letter
Initial scrutiny letter (PDF 17 KB)

Published:

06 June 2007
Eli Lilly response to scrutiny letter
Eli Lilly response to scrutiny letter (PDF 25 KB)

Published:

06 June 2007
Final scrutiny letter
Final scrutiny letter (PDF 17 KB)

Published:

06 June 2007

Lung cancer (non-small cell) - pemetrexed: Result of appeal

Lung cancer (non-small cell) - pemetrexed: Result of appeal
Lung cancer (non-small cell) - pemetrexed: Result of appeal (PDF 43 KB)

Published:

22 August 2007

Appeal

Appeal information

Appeal announcement

Appeal announcement information

Lung cancer (non-small cell) - pemetrexed: final appraisal determination

Lung cancer (non-small cell) - pemetrexed: final appraisal determination information
Evidence considered
Manufacturer submission
Manufacturer submission
Manufacturer submission (PDF 2.72 MB)

Published:

13 November 2006
Clarification response from manufacturer
Clarification response from manufacturer (PDF 194 KB)

Published:

13 November 2006
Expert written personal statements
Baird
Baird (PDF 47 KB)

Published:

13 November 2006
Ferry
Ferry (PDF 58 KB)

Published:

13 November 2006
O'Brien
O'Brien (PDF 27 KB)

Published:

13 November 2006
Sawicka
Sawicka (PDF 37 KB)

Published:

13 November 2006
Pre meeting brief
Pre meeting brief (PDF 69 KB)

Published:

13 November 2006
Lung cancer (non-small-cell) - pemetrexed: evidence review group report
Lung cancer (non-small-cell) - pemetrexed: evidence review group report (PDF 540 KB)

Published:

13 November 2006
Evidence review group report - additional analysis
Evidence review group report - additional analysis (PDF 42 KB)

Published:

13 November 2006
Final matrix
Final matrix (PDF 33 KB)

Published:

13 November 2006
Elizabeth Sawicka
Elizabeth Sawicka (PDF 18 KB)

Published:

15 February 2007
Consultee and Commentator comments on the appraisal consultation document
Cancerbackup
Cancerbackup (PDF 44 KB)

Published:

15 February 2007
Cancer Network Pharmacists forum
Cancer Network Pharmacists forum (PDF 18 KB)

Published:

15 February 2007
Department of Health
Department of Health (PDF 30 KB)

Published:

15 February 2007
Eli Lilly and Company Ltd
Eli Lilly and Company Ltd (PDF 112 KB)

Published:

15 February 2007
Royal College of Nursing
Royal College of Nursing (PDF 25 KB)

Published:

15 February 2007
Royal College of Physicians, the Royal College of Radiologists, the Association of Cancer Physicians, the Joint Collegiate Council for Oncology, and the National Cancer Research Institute Lung Cancer Group
Royal College of Physicians, the Royal College of Radiologists, the Association of Cancer Physicians, the Joint Collegiate Council for Oncology, and the National Cancer Research Institute Lung Cancer Group (PDF 30 KB)

Published:

15 February 2007
Roy Castle Lung foundation
Roy Castle Lung foundation (PDF 23 KB)

Published:

15 February 2007
Sanofi Aventis
Sanofi Aventis (PDF 426 KB)

Published:

15 February 2007
Lung cancer (non-small cell) - pemetrexed: final appraisal determination
Lung cancer (non-small cell) - pemetrexed: final appraisal determination (PDF 73 KB)

Published:

15 February 2007
summary table of Consultee and Commentator comments on the appraisal consultation document
summary table of Consultee and Commentator comments on the appraisal consultation document (PDF 187 KB)

Published:

15 February 2007
summary table of web and public comments on the appraisal consultation document
summary table of web and public comments on the appraisal consultation document (PDF 31 KB)

Published:

15 February 2007
Note on calculations performed at Committee Meeting
Note on calculations performed at Committee Meeting (PDF 30 KB)

Published:

15 February 2007

Pemetrexed for the treatment of non-small-cell lung cancer (appraisal consultation document)

Pemetrexed for the treatment of non-small-cell lung cancer (appraisal consultation document) information